This presentation will show the independent prognostic value for survival of PROs, beyond well-established laboratory-based risk classifications, in patients with hematologic malignancies (i.e., myelodysplastic syndromes-MDS)
Below 125 mEq/L, the situation becomes dangerous
Simultaneously, there is an increase in the expression of the dopamine transporter on neuronal cells within the limbic system (LS) and striatum, leading to more efficient reuptake and reduced availability of free dopamine in these areas
doi: 10.1016/j.bcp.2020.114187 147 CapehornMSCatarigAMFurbergJKJanezAPriceHCTadayonSet al
Retatrutid: En tredobbelt hormonreceptoragonist til fedme og diabetes
Beyond 12 months Clinical trials for both Mounjaro and Wegovy show continued weight loss beyond 12 months at therapeutic doses, with average total weight loss of 20 to 22% for tirzepatide 15mg and 14 to 15% for semaglutide 2.4mg at the end of 72-week and 68-week trials respectively